focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

12 Jun 2013 07:00

RNS Number : 8300G
Sopheon PLC
12 June 2013
 



 

SOPHEON PLC

 

AGM Statement

 

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"We were delighted to report strong growth in 2012 with revenues up by 23% to £12.7m, as well as improvement in profits, with EBITDA growing to £1.8m from £1.5m and profit before tax growing to £281,000 from £104,000. We also strengthened the Group's working capital position by extending the maturity and level of our convertible debt, having paid down the majority of our term loan with BlueCrest Capital. In addition, we shifted our Amsterdam listing from Euronext to Alternext, an exciting market that is a better match for our corporate profile.

 

At the end of 2011 we noted that our strong client base was absorbing much attention from our sales team, resulting in less focus on generating new accounts. We therefore reorganized to drive more balanced attention to both new account acquisition and generating additional growth out of our client base, and this was reflected in a much better performance from new accounts last year. This improvement was underpinned by a major contribution from customers headquartered in new territories such as China and the Middle East. We also saw early fruits of our shift to an agile development methodology with a number of customer-focused releases, culminating in the landmark release of Accolade 8.2 at the start of 2013.

 

On the back of the operating and corporate improvements described above, we ended last year with the confidence to expand headcount in targeted areas of the business, and we have kept shareholders updated on our recruitment activities over recent months. These resources are driving accelerated initiatives for expanded regional sales and marketing, digital marketing programs and product development releases, as well as supplementing our services capacity. This has been achieved through a mix of new hires and fairly extensive subcontracting activity, in part to provide specific skill-sets not yet available from our in house resources. Full year 2013 revenue visibility from contracted business and recurring revenue streams has now risen above £8m, compared to £7.5m at the time of our AGM statement a year ago. This improvement, much of which is represented by services, is encouraging. However, our cost expansion is being undertaken in conjunction with higher internal revenue goals. We are currently working to close a considerable amount of license business, some of which is needed in June to enable first half revenues to exceed the comparable 2012 result.

 

Over the past year we have advised shareholders of our plans to undertake a capital reorganization to consolidate the number of shares and shareholders, and to reduce the accumulated deficit on the profit and loss account. These proposals were formalized and notified to shareholders in a circular dated 1 May, which is available on the Company's website. The proposals will be put to shareholders in a general meeting of the Company, to be held immediately after today's Annual General Meeting."

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Heather Armstrong/ Josh Royston

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

 

Revenue visibility is defined in Note4 of Sopheon's 2012 annual report which is available from the investor section of www.sopheon.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLFFEFRIILLIV
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.